For the Inventor, By the Inventor

Enter assignee name

Los Angeles, CA, United States of America

Abraxis Bioscience, LLC

USPTO Granted Patents = 82

% Expired Patents = 7.3

CIPO Patents = 16

EPO Patents = 55

Trademarks = 13

Forward Citations = 2,598

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Neil P Desai (71 out of 142 patents)

Patrick Soon-Shiong (45 out of 476 patents)

Vuong Trieu (27 out of 35 patents)

4. Willard Foss (8 out of 8 patents)

5. Chunlin Tao (8 out of 32 patents)

6. Viktor Peykov (7 out of 7 patents)

7. Daniel W Pierce (5 out of 11 patents)

8. Andrew Yang (5 out of 15 patents)

9. Tapas De (5 out of 5 patents)

10. Markus Renschler (4 out of 4 patents)

11. Rajesh R Shinde (3 out of 14 patents)

12. Kirk Patrick Seward (3 out of 43 patents)

13. Zachary Yim (3 out of 3 patents)

14. Cheng Zhi Yu (3 out of 3 patents)

15. Qinwei Wang (2 out of 14 patents)

Core Competencies:

Nanoparticle

Therapeutics

Cancer Treatment

Drug Delivery

mTOR Inhibitors

Albumin

Pharmaceutical Compositions

Epithelioid Cell Tumors

Breast Cancer

Lung Cancer

Bladder Cancer

Hepatocellular Carcinoma

82 patents: Sort by Forward Citations

1. 12324860 - Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin (2025-06-10),

2. 12133844 - Methods of treating epithelioid cell tumors (2024-11-05),

3. 12061183 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug (2024-08-13),

4. 11944708 - Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin (2024-04-02),

5. 11497737 - Pharmaceutical compositions of albumin and rapamycin (2022-11-15),

6. 11320416 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug (2022-05-03),

7. 10973806 - Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin (2021-04-13),

8. 10900951 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel (2021-01-26),

9. 10744110 - Methods of treating lung cancer (2020-08-18),

10. 10705070 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug (2020-07-07),

11. 10682420 - Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane (2020-06-16),

12. 10660965 - Methods of enhancing drug delivery and effectiveness of therapeutic agents (2020-05-26),

13. 10555912 - Use of polymeric excipients for lyophilization or freezing of particles (2020-02-11),

14. 10527604 - Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel (2020-01-07),

15. 10413531 - Methods of treating bladder cancer (2019-09-17),

Company Overview

Abraxis Bioscience, LLC is a biotechnology company based in Los Angeles, CA, specializing in nanoparticle therapeutics aimed at advancing cancer treatment. The organization focuses on innovative drug delivery systems that utilize albumin-based nanoparticles to enhance the efficacy of therapeutic agents, particularly mTOR inhibitors. By targeting epithelioid cell tumors and other malignancies, Abraxis aims to improve patient outcomes through its cutting-edge pharmaceutical compositions and delivery technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

82 Patents

#21 in Los Angeles, CA

#1,048 in California

#4,525 in US

#9,258 in the World

Los Angeles, CA, United States of America

Abraxis Bioscience, LLC

Forward Citations = 2,598

29 inventors:

Neil P Desai (71 out of 142 patents)

Patrick Soon-Shiong (45 out of 476 patents)

Vuong Trieu (27 out of 35 patents)

4. Willard Foss (8 out of 8 patents)

5. Chunlin Tao (8 out of 32 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abraxis Bioscience, LLC. Retrieved from https://idiyas.com/company/abraxis-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…